Temozolomide-induced liver damage: A case report

Strahlentherapie und Onkologie

Volumn 190, Issue 4, 2014, Pages 408-410

  Becker, F ^a   Hecht, M ^a   Schmidtner, J ^a   Semrau, S ^a   Fietkau, R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adverse effects; Chemoradiotherapy; Glioblastoma; Hepatitis; Toxicity

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; TEMOZOLOMIDE;

ADULT; ARTICLE; CASE REPORT; CHEMORADIOTHERAPY; DRUG OVERDOSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; JAUNDICE; LIVER INJURY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MIDDLE AGED; RADIATION DOSE; TOXIC HEPATITIS;

ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; DIAGNOSIS, DIFFERENTIAL; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84896933311     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0519-7     Document Type: Article

References (14)

1. Stupp R, Mason WP, Bent MJ van den et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996 (Pubitemid 40349501)
2. Gerstein J, Franz K, Steinbach JP et al (2011) Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution. Strahlenther Onkol 187:722-728
3. Kocher M, Kunze S, Eich HT et al (2005) Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 181:157-163
4. Guckenberger M, Mayer M, Buttmann M et al (2011) Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme. Strahlenther Onkol 187:548-554
5. Balducci M, Apicella G, Manfrida S et al (2010) Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. Strahlenther Onkol 186:558-564
6. Kopecky J, Priester P, Slovacek L et al (2010) Aplastic anemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide. Strahlenther Onkol 186:452-457
7. Schwabe U, Paffrath D (2010) Arzneiverordnungs-Report 2010. Springer Medizin, Berlin
8. Niewald M, Berdel C, Fleckenstein J et al (2011) Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation. Radiat Oncol 6:141
9. Chheda MG, Drappatz J, Greenberger NJ et al (2007) Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note. Neurology 68:955-956 (Pubitemid 46568512)
10. Grewal J, Dellinger CA, Yung WK (2007) Fatal reactivation of hepatitis B with temozolomide. N Engl J Med 356:1591-1592
11. Goldbecker A, Tryc AB, Raab P et al (2011) Hepatic encephalopathy after treatment with temozolomide. J Neurooncol 103:163-166
12. Dixit S, Hingorani M, Afzal P, Campbell AP (2011) Temozolomide induced liver injury. Acta Neurol Belg 111:249-251
13. o A (2011) Arzneimittelkommission der deutschen Ärzteschaft. Dtsch Ärztebl
14. Niyazi M, Schwarz SB, Suchorska B, Belka C (2012) Radiotherapy with and without temozolomide in elderly patients with glioblastoma. Strahlenther Onkol 188:154-159